MedPath

LPN in Patients With High-complex Renal Tumors

Completed
Conditions
Renal Cancer
Renal Cell Carcinoma
Surgery
Oncology
Kidney Injury
Urologic Cancer
Kidney Ischemia
Renal Neoplasm
Urologic Neoplasms
Kidney Neoplasms
Interventions
Procedure: laparoscopic partial nephrectomy
Procedure: Laparoscopic radical nephrectomy
Registration Number
NCT04933604
Lead Sponsor
Samsun Liv Hospital
Brief Summary

The study aims to investigate the rationale for LPN in patients with high-complexity renal tumors in terms of oncologic and functional outcomes.

Detailed Description

From November 2009 to October 2018, 399 patients underwent LPN and 307 patients to laparoscopic radical nephrectomy (LRN). 41 patients with RENAL score ≥ 10 enrolled in LPN and 265 patients to the LRN group. Propensity score matching (matched by age, gender, clinical tumor stage, tumor size, baseline renal function, comorbidities such as diabetes mellitus (DM), hypertension (HT), coronary artery disease (CAD), and final tumor pathology of RCC) was used to reduce selection bias. Functional and oncological outcomes were compared between the two groups. After propensity score analysis, 39 patients in the LRN group were matched with 39 in the LPN group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Patients with complete data
  • Patients with single renal tumor on the effected side
  • Patients who approved the written consent form
Exclusion Criteria
  • Patients who not approved the written consent form
  • Patients with incomplete data
  • Patients with low or mild complexity renal tumors

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
LPN grouplaparoscopic partial nephrectomy39 patients with high complexity renal tumors who underwent laparoscopic partial nephrectomy
LRN groupLaparoscopic radical nephrectomy39 patients with high complexity renal tumors who underwent laparoscopic radical nephrectomy
Primary Outcome Measures
NameTimeMethod
Postoperative complicationup to 3 months postoperatively

abnormal problmes that may be seen after surgery and require additional intervention, treatment or follow-up

functional outcomes1 year after the surgery

serum creatinine level (mg /dL) and estimated glomerular filtration rate (CKD Epidemiology Collaboration (CKD-EPI) equation) (mL/min/1.73 m2)

surigcal margin statuspostoperative follow-up, through study completion, an average of 1 year

presence or absence of tumors at the surgical margin

CKD stage upgradingpostoperative follow-up, through study completion, an average of 1 year

evaluation of preoperative and postoperative renal functions according to chronic kidney disease stages

Oncological outomespostoperative follow-up, through study completion, an average of 1 year

Presence or absence of local and/or distal tumor recurrence

Operation timeat the end of the surgery

time from onset to complete of surgery

Blood lossat the end of the surgery

amount of bleeding during surgery (mL)

warm ischemia timeat the and of the surgery

The clamp time of the renal artery and vein which is required to complete tumor excision and renorrhaphy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ondokuz Mayıs University, Department of Urology

🇹🇷

Samsun, Turkey

© Copyright 2025. All Rights Reserved by MedPath